Endometrial cancer classification: Difference between revisions
Jump to navigation
Jump to search
Line 22: | Line 22: | ||
| style="background:#F5F5F5;" align="center" + |Endometroid (adenocarcinoma) | | style="background:#F5F5F5;" align="center" + |Endometroid (adenocarcinoma) | ||
| style="background:#F5F5F5;" align="center" + |Favorable (estrogen-responsive) | | style="background:#F5F5F5;" align="center" + |Favorable (estrogen-responsive) | ||
| style="background:#F5F5F5;" align="center" + | | | style="background:#F5F5F5;" align="center" + |• May arise from atypical hyperplasia </br> • Linked to unopposed estrogen stimulation | ||
| style="background:#F5F5F5;" align="center" + |80% | | style="background:#F5F5F5;" align="center" + |80% | ||
|- | |- | ||
| style="background:#DCDCDC;" align="center" + |Type II | | style="background:#DCDCDC;" align="center" + |Type II | ||
| style="background:#F5F5F5;" align="center" + | | | style="background:#F5F5F5;" align="center" + |• Endometroid </br>• Serous </br>• Clear cell </br>• Mucinous </br>• Squamous </br>• Mesonephric </br>• Undifferentiated | ||
| style="background:#F5F5F5;" align="center" + |Typically bad prognosis | | style="background:#F5F5F5;" align="center" + |Typically bad prognosis | ||
| style="background:#F5F5F5;" align="center" + | | | style="background:#F5F5F5;" align="center" + |• Develops from atrophic endometrium </br>• Not linked to hormonally driven pathogenesis | ||
| style="background:#F5F5F5;" align="center" + |15-20% | | style="background:#F5F5F5;" align="center" + |15-20% | ||
|} | |} |
Revision as of 18:33, 26 November 2018
Endometrial cancer Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Endometrial cancer classification On the Web |
American Roentgen Ray Society Images of Endometrial cancer classification |
Risk calculators and risk factors for Endometrial cancer classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Monalisa Dmello, M.B,B.S., M.D. [2]
Overview
Endometrial cancer may be classified according to histology into either type I comprising 80% of endometrial cancers or type II accounting for around 20%.
Classification
Endometrial cancer may be classified according to histology into 2 types:
- Type I
- Type II
Type | Histology | Prognosis | Pathogenesis | Prevalence |
---|---|---|---|---|
Type I | Endometroid (adenocarcinoma) | Favorable (estrogen-responsive) | • May arise from atypical hyperplasia • Linked to unopposed estrogen stimulation |
80% |
Type II | • Endometroid • Serous • Clear cell • Mucinous • Squamous • Mesonephric • Undifferentiated |
Typically bad prognosis | • Develops from atrophic endometrium • Not linked to hormonally driven pathogenesis |
15-20% |
Classification Based on Pathogenesis
- Endometrial cancers are classified into either type 1 or type 2:[1]
- Type 1 may arise from complex atypical hyperplasia and is pathogenetically linked to unopposed estrogenic stimulation.
- Type 2 develops from atrophic endometrium and is not linked to hormonally driven pathogenesis.
Classification Based on Histopathological Subtype
There are 7 subtypes of endometrial cancer based on histopathology:
- 1. Endometrioid (75%–80%)(The most common endometrial cancer cell type is endometrioid adenocarcinoma, which is composed of malignant glandular epithelial elements)
- Ciliated adenocarcinoma
- Secretory adenocarcinoma
- Papillary or villoglandular
- Adenocarcinoma with squamous differentiation
- Adenoacanthoma
- Adenosquamous (Adenosquamous tumors contain malignant elements of both glandular and squamous epithelium)
- 2. Uterine papillary serous (<10%)
- 3. Mucinous (1%)
- 4. Clear cell (4%)
- 5. Squamous cell (<1%)
- 6. Mixed (10%)
- 7. Undifferentiated